Exosomes Market Growth, Top Players, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Exosomes Market covers analysis By Product and Service (Kits and Reagents, Instruments, Services); Type (Non-Coding RNAs, mRNA, Proteins, DNA Fragments, Lipids, Others); Application (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00004909
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW



Exosomes are extracellular vesicles that contain the elements of the cells that produce them, such as proteins, lipids, nucleic acids, RNA, DNA, and metabolites. They are actually taken up by distant cells, where they perform diverse functions and exhibit distinct behaviors. It is utilized to keep the cells in a state of equilibrium by eliminating unwanted elements. It can deliver a variety of therapeutic payloads, including as short interfering RNAs, chemotherapeutic drugs, antisense oligonucleotides, and immune modulators, to a specific target.

MARKET SCOPE



The "Global Exosomes Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the exosomes market with detailed market segmentation by product and services, type, application, and geography. The report provides key statistics on the market status of the leading exosomes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on product and services, the market is bifurcated into kits and reagents, instruments, and services
  •   Based on type, the market is bifurcated into non-coding RNAs, mRNA, proteins, DNA fragments, lipids, and others
  •   Based on application, the market is bifurcated into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others

MARKET DYNAMICS


Drivers:



  •   Increasing prevalence of cancer
  •   Advanced applications of exosomes

Restraints:



  •   Stringent regulations pertaining to approval

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The exosomes market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the exosomes market in these regions.

IMPACT OF COVID-19 ON EXOSOMES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the exosomes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from exosomes market are anticipated to lucrative growth opportunities in the future with the rising demand for health coach in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the exosomes market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Bio-Techne
  •   Illumina, Inc.
  •   Thermo Fisher Scientific, Inc.
  •   Diagenode S.A.
  •   Hitachi Chemical Diagnostics, Inc.
  •   QIAGEN
  •   Takara Bio, Inc.
  •   Lonza
  •   Beckman Coulter, Inc.
  •   Miltenyi Biotec
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Exosomes Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product and Service
  • Kits and Reagents
  • Instruments
  • Services
By Type
  • Non-Coding RNAs
  • mRNA
  • Proteins
  • DNA Fragments
  • Lipids
By Application
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bio-Techne
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Diagenode S.A.
  • Hitachi Chemical Diagnostics, Inc.
  • QIAGEN
  • Takara Bio, Inc.
  • Lonza
  • Beckman Coulter, Inc.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    exosomes-market-report-deliverables-img1
    exosomes-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Bio-Techne
    2. Illumina, Inc.
    3. Thermo Fisher Scientific, Inc.
    4. Diagenode S.A.
    5. Hitachi Chemical Diagnostics, Inc.
    6. QIAGEN
    7. Takara Bio, Inc.
    8. Lonza
    9. Beckman Coulter, Inc.
    10. Miltenyi Biotec
    11. Fujifilm Holdings Corporation
    12. MBL International
    13. Novus Biologicals
    14. Danaher (Beckman Coulter Inc.)
    15. Takara Bio Company
    16. Malvern Instruments Ltd.
    exosomes-market-cagr